Mazen Animal Health, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Mazen Animal Health, Inc. - overview
Established
2015
Location
Ames, IA, US
Primary Industry
Biotechnology
About
Based in Missouri, US, and founded in 2015, Mazen Animal Health, Inc. operates as a biotechnology company that focuses on developing and commercializing novel biological vaccines and therapeutics that disrupt the status quo and address complex and unresolved challenges for animal health. The company was founded by Jenny Filbey, Ph. D.
In January 2019, Mazen Animal Health, Inc. raised an undisclosed amount of seed funding from Innovation in Motion. The company's line of products is to develop swine, poultry, livestock, aquaculture, and pets vaccine solutions for a wide variety of diseases. Mazen Animal Health, Inc.
plans to expand into companion animals, poultry, fish, and other species.
Current Investors
Innovation in Motion, Summit Ag Investors, Ag Ventures Alliance
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Pharmaceutical Research & Development
Website
www.mazenanimalhealth.com
Company Stage
Series A
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.